Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

NCT00711854 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

MRSA Infection

Interventions

DRUG: trimethoprim-sulfamethoxazole (TMP-SMX)
DRUG: Linezolid
DRUG: Rifampicin

Sponsor

University Hospital, Geneva